Prevalence and impact of airway diseases on clinical outcomes in idiopathic pulmonary fibrosis
Heemoon Park, Jaeyoung Cho, Jinwoo Lee, Young Sik Park, Chang-Hoon Lee, Sang-Min Lee, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Sun Mi Choi
Korean J Intern Med. 2022;37(2):387-397. Published online 2021 Dec 7 DOI: https://doi.org/10.3904/kjim.2021.025
|
Citations to this article as recorded by
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Gabriele De Rubis, Keshav Raj Paudel, Leander Corrie, Samir Mehndiratta, Vyoma K. Patel, Popat S. Kumbhar, Arehalli Sidramappa Manjappa, John Disouza, Vandana Patravale, Gaurav Gupta, Bikash Manandhar, Rashi Rajput, Alexandra Kailie Robinson, Ruby-Jean Re
Naunyn-Schmiedeberg's Archives of Pharmacology.2024; 397(5): 2793. CrossRef Advanced lung organoids for respiratory system and pulmonary disease modeling
Hyebin Joo, Sungjin Min, Seung-Woo Cho
Journal of Tissue Engineering.2024;[Epub] CrossRef The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis
Rhiannon Green, Michael Baldwin, Nick Pooley, Kate Misso, Maureen PMH Rutten-van Mölken, Nina Patel, Marlies S. Wijsenbeek
Respiratory Research.2024;[Epub] CrossRef Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
Jang Ho Lee, Hyung Jun Park, Seonok Kim, Ye-Jee Kim, Ho Cheol Kim
BMC Pulmonary Medicine.2023;[Epub] CrossRef Comorbidities and Causes of Death of Patients With Asbestosis
Eerika Keskitalo, Johanna Salonen, Hanna Nurmi, Hannu Vähänikkilä, Riitta Kaarteenaho
Journal of Occupational & Environmental Medicine.2023; 65(4): 349. CrossRef
|